Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

XCyton Diagnostics develops new diagnostic technology

XCyton Diagnostics, a molecular biology company, has developed a new diagnostic technology to diagnose multiple organisms responsible for infections.

The system can identify multiple organisms including bacteria, viruses, fungi and parasites in a specific test from a single sample.

Xcyton said diagnostic cultures are used to identify infectious microbes, parasites from samples isolated from blood, spinal cord, urine, stool, genital tract, throat and skin.

Biocon chairman and managing director Kiran Mazumdar-Shaw was quoted by health.india as saying that the company’s founder invested an undisclosed capital in XCyton a few years back, when it was struggling to sell its products in the market and was not able to get grants to pursue scientific research.

Amvar Ventures, a sister concern of Nadathur Holdings and a co-founder of Infosys, has also invested into XCyton Diagnostics.